The Rise of Testosterone Replacement Therapy for Men

Published 28 November 2024

2 min read

Boosted by an ageing population (men experience testosterone reduction with age), the global testosterone replacement therapy (TRT) market is expected to grow from $1.9bn in 2022 to $2.5bn by 2030 (GlobeNewsWire, 2024). While 20% of men over 60 have low testosterone levels (Nature, 2024), some younger men are also seeking TRT to enhance their mood, libido and physique.

  • Mastering the Andropause: Middle-aged men are increasingly using TRT to address andropause (often described as ‘male menopause’) symptoms, which can appear in their late 40s. Symptoms include depression, low libido, erectile dysfunction, insomnia and muscle loss.

    Men’s health clinics offering middle-aged men TRT are proliferating in response. Peak demand comes from men aged 50 to 60, says Channa Jayasena, a reproductive endocrinology consultant at Imperial College London. British clinic Optimale provides hormone blood tests and TRT, while US clinic South Florida Men’s Health similarly offers TRT injections, implants and creams. And American brand The Vitamin Shoppe is selling oral TRT, which is prescribed after recipients complete a questionnaire, lab work and virtual consultancy.

Optimale

The Vitamin Shoppe

Optimale

The Vitamin Shoppe

See Refining Modern Masculinity and Medtech’s Next Era for more.